When do biologic drug patents expire and when will biosimilars launch?

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Patent Expiration
Grifols Therapeutics Llc	BAYGAM, GAMASTAN S/D	immune globulin (human)	Injection	101134	1944-01-11	⤷ Subscribe	⤷ Subscribe
Grifols Therapeutics Llc	BAYRHO-D, HYPRHO-D, HYPERRHO S/D FULL DOSE, HYPERRHO S/D MINI-DOSE	rho(d) immune globulin (human)	Injection	101141	1971-06-11	⤷ Subscribe	⤷ Subscribe
Grifols Therapeutics Llc	BAYHEP B, HYPERHEP B S/D	hepatitis b immune globulin (human)	Injection	101146	1977-09-23	⤷ Subscribe	⤷ Subscribe
Csl Behring Ag	CYTOGAM	cytomegalovirus immune globulin intravenous (human)	Injection	103189	1990-04-17	⤷ Subscribe	⤷ Subscribe
Saol Therapeuctics Research Limited	WINRHO SD, WINRHO SDF LIQUID, WINRHO SDF LYOPHILIZED	rho(d) immune globulin intravenous (human)	For Injection	103649	1996-04-02	⤷ Subscribe	⤷ Subscribe
Pharmacia & Upjohn Company	ATGAM	lymphocyte immune globulin, anti-thymocyte globulin (equine)	Injection	103676	1996-12-04	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Patent Expiration